CHRONOtype-adjusted DIET on Weight Loss
- Conditions
- Obesity
- Interventions
- Procedure: CHRONOTYPE-ADJUSTED DIET
- Registration Number
- NCT03755674
- Lead Sponsor
- Universidad Católica San Antonio de Murcia
- Brief Summary
BACKGROUND: Several reports have observed that the alteration of normal biological rhythms is associated with obesity development. In this regard, those subject with the preference for evening seems to be prone to develop obesity. However, the current treatment of obesity does not take into account these aspects OBJECTIVE: To evaluate whether a diet adjusted to patient's chronotype is more effective than the current dietary recommendations.
SUBJECTS/METHODS: 209 subjects take part in a randomized, double-blind clinical trial. 104 subjects followed a typical hypocaloric dietary treatment (CONTROL) and the other 105 subjects undergone a diet with a daily caloric distribution adjusted to their chronotype (CHRONO).
CONCLUSIONS: A chronotype-adjusted diet may be a promising alternative to the classical hypocaloric dietary treatment since the investigator's data indicate a higher effectiveness regarding weight loss when the diet was adjusted to the patient's chronotype.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 96
- students or staff of the Catholic University of Murcia (UCAM), with an age ranged between 18 and 65 years old
- clinically significant illnesses (including type 2 diabetes, chronic heart failure, hepatitis and cancer)
- those taking any medications known to affect body weight (thyroid hormones, corticosteroids, etc.)
- women in special physiological situations (pregnant, lactating).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description CHRONOTYPE-ADJUSTED DIET CHRONOTYPE-ADJUSTED DIET Patients that undergo a chronotype adjusted diet
- Primary Outcome Measures
Name Time Method Total weight loss, in percentage, from baseline to end-of-treatment 12 weeks Percentage of weight loss, measured with a scale, from baseline weight (100% body weight) since body weight after 12 weeks of treatment (final body weight). Percentage of body weight was then measured as Total Weight Loss (%) = (Final body weight - Baseline body weight) / baseline body weight x 100.
- Secondary Outcome Measures
Name Time Method Anthropometrical and other clinical parameters 12 weeks Improvement of anthropometrical and other clinical parameters during the treatment
BMI loss 12 weeks BMI decrease from baseline